Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$66.25 +0.79 (+1.21%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Operating Margin (2010 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) recorded Operating Margin of -226.03% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 370.18 percentage points from -596.21% a year earlier but down 34.46 percentage points from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Operating Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Arrowhead Pharmaceuticals' Operating Margin came in at -33.82% as of Jun 30, 2026, down 14.98 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at 11.86%, up 16938.92 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of +117.73 percentage points (FY2020 to FY2025).
  • Across earlier fiscal years, Operating Margin came in at -16927.06% in FY2024 (-16841.91 pp), -85.16% in FY2023 (-11.77 pp), -73.39% in FY2022 (+34.38 pp) and -107.77% in FY2021 (-1.90 pp).
  • Quarterly Operating Margin has ranged from -6456.48% in fiscal Q1 2025 to 70.24% in fiscal Q2 2025 over the past five years.
  • On a year-over-year basis, Operating Margin rose in two of the last four quarters, with an average year-over-year change of +992.27 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 6471.94 percentage points in fiscal Q1 2026, against a drop of 3777.89 percentage points in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -191.57% (Q2 2026), 15.46% (Q1 2026) and 17.20% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - -226.03%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -226.03%
Mar 31, 2026 -191.57%
Dec 31, 2025 15.46%
Sep 30, 2025 17.20%
Jun 30, 2025 -596.21%
Mar 31, 2025 70.24%
Dec 31, 2024 -6,456.48%
Dec 31, 2023 -3,845.25%
Sep 30, 2023 -672.98%
Jun 30, 2023 -648.99%
Mar 31, 2023 32.93%
Dec 31, 2022 -67.36%
Sep 30, 2022 -265.49%
Jun 30, 2022 -224.94%
Mar 31, 2022 27.37%
Dec 31, 2021 -230.77%
Sep 30, 2021 -169.48%
Jun 30, 2021 -69.44%
Mar 31, 2021 -86.04%
Dec 31, 2020 -112.91%
API Access

Arrowhead Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEY